Waander L. van Heerde

Biochemist, Coagulation Physiologist, Chief Scientific Officer Enzyre BV
Department of Hematology, Radboud university medical center, Nijmegen, The Netherlands. Hemophilia Treatment Center Nijmegen – Eindhoven – Maastricht, The Netherlands. Enzyre BV, Novio Tech Campus, Nijmegen, The Netherlands.
Nijmegen, Gelderland, Netherlands

Presentation(s):

• OC 12.2 - Decreased quality of life in non-severe hemophilia patients with an increased bleeding phenotype

  Sunday, June 25, 2023
  11:00 – 11:15 ET

• PB0203 - Altered Bleeding Phenotype in Patients with Co-inheritance of Genetic Variants in Thrombosis and Hemostases Genes in Rare Bleeding Disorders

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0205 - High prevalence of heavy menstrual bleeding in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study

  Sunday, June 25, 2023
  18:30 – 19:30 ET